Welcome

The Michigan Society of Hematology and Oncology (MSHO) is a non-profit 501c(6) corporation, formed in 1985 to address the growing needs of oncologists, radiation oncologists and hematologists in all practice settings in the state.

It is the Mission of MSHO to promote exemplary care for patients with cancer and/or blood disorders through advocacy, education and research.

Upcoming Events view all events

←	November 2020					→
S	M	T	W	T	F	S
1 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020	2 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020	3 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020	4 MSHO Payer Update Webinar Series WPS Medicare November 4, 2020 12:00-1:00PM Hospitals: Clinical Overview and Use of Quzyttir - Learn More About the First and Only 2nd Generation IV Antihistamine Hosted by TerSera A Virtual Event - Multiple Broadcast Times November 4, 2020 AONN 11th Annual Navigation & Survivorship Conference Virtual Experience November 4-8, 2020 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020	5 MSHO's Oncology Nursing Education Series Precision Therapy for Non-Small Cell Lung Cancer November 5, 2020 12:00-1:00PM AONN 11th Annual Navigation & Survivorship Conference Virtual Experience November 4-8, 2020 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020	6 AONN 11th Annual Navigation & Survivorship Conference Virtual Experience November 4-8, 2020 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020	7 AONN 11th Annual Navigation & Survivorship Conference Virtual Experience November 4-8, 2020 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020
8 AONN 11th Annual Navigation & Survivorship Conference Virtual Experience November 4-8, 2020 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020	9 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020	10 New Evidence in First-Line AML and Exploring Outcomes with Fixed-Duration Treatment in CLL Hosted by AbbVie A Virtual Event - Multiple Broadcast Times November 10, 2020 Infusion Centers: Clinical Overview and Use of Quzyttir - Learn More About the First and Only 2nd Generation IV Antihistamine Hosted by TerSera A Virtual Event - Multiple Broadcast Times November 10, 2020 Clinical Insights From Real-World Cases: The Patient Journey From Diagnosis Through CALQUENCE Treatment A Virtual Event - Multiple Broadcast Times November 10, 2020 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020	11 Treatment Considerations in Polycythemia Vera and Myelofibrosis: Real-World Patient Case Discussion Hosted by Incyte Dearborn, MI November 11, 2020 6:00-8:00PM MSHO Payer Update Webinar Series Priority Health November 11, 2020 12:00-1:00PM LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020	12 MSHO's Oncology Nursing Education Series Identification and Treatment of Potential Victims of Human Trafficking in the Clinical Setting November 12, 2020 12:00-1:00PM Jazz Promotional Program with Dr. Nadler Hosted by Jazz Pharmaceuticals A Virtual Event - Multiple Broadcast Times November 12, 2020 New Evidence in First-Line AML and Exploring Outcomes with Fixed-Duration Treatment in CLL Hosted by AbbVie A Virtual Event - Multiple Broadcast Times November 12-17, 2020 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020	13 New Evidence in First-Line AML and Exploring Outcomes with Fixed-Duration Treatment in CLL Hosted by AbbVie A Virtual Event - Multiple Broadcast Times November 12-17, 2020 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020	14 Progress in Breast Cancer Care, Advocacy and Survivorship Hosted by Dynami Foundation Virtual Symposium November 14, 2020 10:30AM-12:30PM New Evidence in First-Line AML and Exploring Outcomes with Fixed-Duration Treatment in CLL Hosted by AbbVie A Virtual Event - Multiple Broadcast Times November 12-17, 2020 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020
15 New Evidence in First-Line AML and Exploring Outcomes with Fixed-Duration Treatment in CLL Hosted by AbbVie A Virtual Event - Multiple Broadcast Times November 12-17, 2020 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020	16 New Evidence in First-Line AML and Exploring Outcomes with Fixed-Duration Treatment in CLL Hosted by AbbVie A Virtual Event - Multiple Broadcast Times November 12-17, 2020 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020	17 AMA's CPT and RBRVS 2021 Annual Symposium Virtual Experience November 17-20, 2020 New Evidence in First-Line AML and Exploring Outcomes with Fixed-Duration Treatment in CLL Hosted by AbbVie A Virtual Event - Multiple Broadcast Times November 12-17, 2020 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020	18 ASH Grassroots Network Lunch on November 18 A Virtual Event November 18, 2020 3:00-4:00PM AMA's CPT and RBRVS 2021 Annual Symposium Virtual Experience November 17-20, 2020 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020	19 An Individualized Approach: A CDK4 & 6 Inhibitor for Women With Reduced Survival in HR+, HER2-MBC Hosted by Lilly Oncology A Virtual Event November 19, 2020 7:00-9:00PM MSHO's Oncology Nursing Education Series Managing Side Effects from Immunotherapy November 19, 2020 12:00-1:00PM AMA's CPT and RBRVS 2021 Annual Symposium Virtual Experience November 17-20, 2020 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020	20 AMA's CPT and RBRVS 2021 Annual Symposium Virtual Experience November 17-20, 2020 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020	21 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020
22 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020	23 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020	24 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020	25 MSHO Office Closure Thanksgiving Holiday November 25-27, 2020 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020	26 MSHO Office Closure Thanksgiving Holiday November 25-27, 2020 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020	27 MSHO Office Closure Thanksgiving Holiday November 25-27, 2020 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020	28 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020
29 LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020	30 Insight Into Caregiving Hosted by Leukemia & Lymphoma Society A Virtual Event November 30, 2020 1:00-2:00PM LYNPARZA as Maintenance Monotherapy or Combination Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials Hosted by AstraZeneca A Virtual Event - Multiple Broadcast Times September 23 - December 3, 2020